GGrantIndex
Sort

141,003 grants matching cytokine

Mitochondrial DNA and Sex Differences in Scleroderma-Associated ILD

$1,498,380
Erica L Herzog · Yale University · R01 · FY2025 · HL

LcrV Plague Vaccine with Altered Immune Modulatory Properties

$1,498,357
Olaf Schneewind · University Of Chicago · U01 · FY2007 · AI

Pathogenesis and Treatment of HIV Infection

$1,498,149
Henry C Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer

$1,497,616
Howard C Crawford · University Of Michigan At Ann Arbor · U01 · FY2017 · CA

COSTIMULATION AND CYTOKINES IN TOLERANCE

$1,497,188
Laurence A Turka · University Of Pennsylvania · P01 · FY2006 · AI

Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trial

$1,497,170
Michael E Wechsler · National Jewish Health · U01 · FY2014 · AI

Gene Therapy for Inherited Blood Disorders

$1,497,052
Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Cellular and Molecular Studies of Bone Marrow Transplant

$1,496,702
University Of Michigan At Ann Arbor · P01 · FY2005 · CA

improving outcomes after stem cell transplantation

$1,496,532
Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL

MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG

$1,496,173
University Of Miami School Of Medicine · U01 · FY2005 · AI

Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)

$1,496,150
Andrea Lynne Gropman · Children'S Research Institute · U54 · FY2023 · HD

Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD)

$1,496,118
Christopher M Jewell · Cartesian Therapeutics, Inc. · R44 · FY2024 · NS

Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD)

$1,496,118
Charles Andrew Stewart · Cartesian Therapeutics, Inc. · R44 · FY2025 · NS

COSTIMULATION AND CYTOKINES IN TOLERANCE

$1,496,088
University Of Pennsylvania · P01 · FY2005 · AI

Inflammation, Airways Reactivity and Asthma

$1,495,899
National Jewish Health · P01 · FY2003 · HL

Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections

$1,495,694
Michael E Selsted · University Of Southern California · R01 · FY2016 · AI

Application of Flow Cytometry to Cell Biology

$1,494,868
Susan Sharrow · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases

$1,494,684
Chi-Chao Chan · National Eye Institute · ZIA · FY2011 · EY

Diesel, Allergens and Gene Interaction and Child Atopy

$1,493,913
University Of Cincinnati · R01 · FY2002 · ES

Identification of human genes of iron homeostasis

$1,493,550
Caroline Philpott · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

Interleukin 4

$1,493,478
William Paul · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Role of inflammation, innate resistance, and immunity in carcinogenesis.

$1,493,249
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Viral and Host Determinants of Infant and Childhood Allergy and Asthma

$1,493,162
Ray Stokes Peebles · Vanderbilt University Medical Center · U19 · FY2022 · AI

HSC DIFFERENTIATION

$1,492,969
Children'S Hospital Los Angeles · P50 · FY2002 · HL

Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection

$1,492,743
Aileen Chang · George Washington University · U01 · FY2023 · AR